INSIGHTS ON DRUG DEVELOPMENT
-
Evolving Gene Editing For Rare Disease Drug Development
Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
-
Can Collaboration Close Biopharma's Talent Gap For Good?
Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
The Complete Flow Cytometry Guide
This guide covers the fundamentals of flow cytometry, aiming to help you better understand how it works, when it is most valuable, and how to conduct an experiment.
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients1/7/2026
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Multiplex Imaging3/24/2025
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Take Action On PFAS To Protect Your Critical Processes9/18/2025
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
DRUG DEVELOPMENT SOLUTIONS
-
Our comprehensive network of manufacturing facilities enables us to offer robust supply assurance and consistent product quality to biopharmaceutical developers around the globe.
-
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
Leica DM750 Binocular
For a Student Friendly Classroom Environment
The Leica DM750 is the ideal microscope for the versatile needs of advanced college and university life science courses and professional training in medical, veterinary and dental schools.
-
See More with Microflow LC-MS
The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
-
The systems can be provided in sterile, toxic or sterile toxic arrangements with the great advantage of being 100 % scalable.